Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Finance question

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Dec 03, 2021 10:09am

457 Views

Post# 34194381

RE:RE:RE:Finance question

NgamiaSwede wrote: Rumpl3

I have seen this before, in that time the shelf was pulled to make a partner more willing to grab. When you want a bite you do not want the bite to be smaller after a while because new shares come in play

Best Regards Mikael

Ah, yes Swede. That does make sense, could also explain letting the 37.5c warrants expire instead of extendig them. Smaller float to sweeten the deal!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario